Safety and Efficacy of Inhaled XW001 For Hospitalized COVID-19 Patients Requiring Oxygen Therapy

NCT05083117 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Difficulty in COVID-19 subject enrollment

Conditions

COVID-19 Acute Respiratory Distress Syndrome

Interventions

DRUG: XW001
DRUG: Placebo

Sponsor

Sciwind Biosciences APAC CO Pty. Ltd.

Collaborators

[object Object]
[object Object]